Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K, Stolk WA, Basáñez MG, Collyer BS, de Vlas SJ, Diggle PJ, Gass K, Graham M, Hollingsworth TD, King JD, Krentel A, Anderson RM, Coffeng LE. Kura K, et al. Among authors: gass k. Clin Infect Dis. 2024 Apr 25;78(Supplement_2):S93-S100. doi: 10.1093/cid/ciae021. Clin Infect Dis. 2024. PMID: 38662701 Free PMC article.
Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.
Antony Oliver MC, Graham M, Gass KM, Medley GF, Clark J, Davis EL, Reimer LJ, King JD, Pouwels KB, Hollingsworth TD. Antony Oliver MC, et al. Among authors: gass km. Clin Infect Dis. 2024 Apr 25;78(Supplement_2):S160-S168. doi: 10.1093/cid/ciae108. Clin Infect Dis. 2024. PMID: 38662697 Free PMC article.
Diagnostics to support elimination of lymphatic filariasis-Development of two target product profiles.
Won KY, Gass K, Biamonte M, Dagne DA, Ducker C, Hanna C, Hoerauf A, Lammie PJ, Njenga SM, Noordin R, Ramaiah KD, Ramzy R, Scholte RGC, Solomon AW, Souza AA, Tappero J, Toubali E, Weil GJ, Williams SA, King JD. Won KY, et al. Among authors: gass k. PLoS Negl Trop Dis. 2021 Nov 15;15(11):e0009968. doi: 10.1371/journal.pntd.0009968. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34780503 Free PMC article.
Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions.
Biamonte MA, Cantey PT, Coulibaly YI, Gass KM, Hamill LC, Hanna C, Lammie PJ, Kamgno J, Nutman TB, Oguttu DW, Sankara DP, Stolk WA, Unnasch TR. Biamonte MA, et al. Among authors: gass km. PLoS Negl Trop Dis. 2022 Aug 3;16(8):e0010682. doi: 10.1371/journal.pntd.0010682. eCollection 2022 Aug. PLoS Negl Trop Dis. 2022. PMID: 35921329 Free PMC article.
Assessment of the required performance and the development of corresponding program decision rules for neglected tropical diseases diagnostic tests: Monitoring and evaluation of soil-transmitted helminthiasis control programs as a case study.
Levecke B, Coffeng LE, Hanna C, Pullan RL, Gass KM. Levecke B, et al. PLoS Negl Trop Dis. 2021 Sep 14;15(9):e0009740. doi: 10.1371/journal.pntd.0009740. eCollection 2021 Sep. PLoS Negl Trop Dis. 2021. PMID: 34520474 Free PMC article.
Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
Johnson O, Giorgi E, Fronterrè C, Amoah B, Atsame J, Ella SN, Biamonte M, Ogoussan K, Hundley L, Gass K, Diggle PJ. Johnson O, et al. Among authors: gass k. PLoS Negl Trop Dis. 2022 Feb 9;16(2):e0010189. doi: 10.1371/journal.pntd.0010189. eCollection 2022 Feb. PLoS Negl Trop Dis. 2022. PMID: 35139080 Free PMC article.
66 results